Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)

Maria Fleseriu, Beverly M.K. Biller, Jérôme Bertherat, Jacques Young, Betul Hatipoglu, Giorgio Arnaldi, Paul O’Connell, Miguel Izquierdo, Alberto M. Pedroncelli, Rosario Pivonello

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)'. Together they form a unique fingerprint.

Medicine & Life Sciences